Stockscreener 앱 받기
79.21
0.45%
-0.16
Nuvalent Inc 주식(NUVL)의 최신 뉴스
CEO Change: Is Nuvalent Inc benefiting from innovation trendsQuarterly Performance Summary & Reliable Price Breakout Alerts - خودرو بانک
Will Nuvalent Inc benefit from green energy policiesJuly 2025 Action & Free High Accuracy Swing Entry Alerts - خودرو بانک
Market Outlook: Is Nuvalent Inc benefiting from innovation trends2025 Biggest Moves & Fast Gain Swing Alerts - خودرو بانک
Stock Analysis: What makes Nuvalent Inc. stock attractive todayJuly 2025 Spike Watch & Fast Gain Swing Trade Alerts - خودرو بانک
Income Plays: Is Nuvalent Inc. in a bullish channelWeekly Investment Recap & Community Driven Trade Alerts - خودرو بانک
Fred Alger Management LLC Sells 120,155 Shares of Nuvalent, Inc. $NUVL - MarketBeat
20,994 Shares in Nuvalent, Inc. $NUVL Purchased by Voleon Capital Management LP - MarketBeat
Nuvalent (NASDAQ:NUVL) Insider Sells 3,725 Shares - MarketBeat
Nuvalent (NASDAQ:NUVL) Given "Outperform" Rating at Wedbush - MarketBeat
Is Nuvalent Inc. reversing from oversold territoryJuly 2025 Intraday Action & Safe Entry Point Alerts - newser.com
Nuvalent, Inc. $NUVL Shares Sold by Polar Asset Management Partners Inc. - MarketBeat
Alyeska Investment Group L.P. Decreases Stock Position in Nuvalent, Inc. $NUVL - MarketBeat
Nuvalent, Inc. $NUVL Stake Cut by Adage Capital Partners GP L.L.C. - MarketBeat
Nuvalent (NASDAQ:NUVL) Coverage Initiated at Guggenheim - MarketBeat
Nuvalent, Inc. $NUVL Shares Purchased by Parkman Healthcare Partners LLC - MarketBeat
What makes Nuvalent Inc. stock attractive todayJuly 2025 Volume & Real-Time Volume Trigger Notifications - Lancaster City Council
Can Nuvalent Inc. grow without external fundingLong Setup & Daily Growth Stock Investment Tips - Lancaster City Council
Raymond James Keeps Their Buy Rating on Nuvalent (NUVL) - The Globe and Mail
Drawdown in Nuvalent Inc. May Be Nearing End2025 Analyst Calls & Stock Timing and Entry Methods - beatles.ru
Harpreet Singh Showcases Biotech on the Main Stage at WCLC2025 - Oncodaily
Piper Sandler Initiates Nuvalent (NUVL) Amid Key Cancer Drug Catalysts - MSN
Walleye Capital LLC Sells 42,253 Shares of Nuvalent, Inc. $NUVL - MarketBeat
Nuvalent Presents Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-positive NSCLC at WCLC 2025 - StreetInsider
Breaking Lung Cancer Treatment Advance: Nuvalent's Zidesamtinib Shows Promise in Critical NSCLC Trial - Stock Titan
Nuvalent Inc. Sees Spike in Bullish Option FlowJuly 2025 Catalysts & Free Weekly Chart Analysis and Trade Guides - beatles.ru
Nuvalent, Inc. $NUVL is Vestal Point Capital LP's 4th Largest Position - MarketBeat
Is it too late to sell Nuvalent Inc.July 2025 Update & AI Forecast Swing Trade Picks - Newser
Can momentum traders help lift Nuvalent Inc.2025 Price Momentum & Fast Gain Stock Trading Tips - Newser
When is the best time to exit Nuvalent Inc.Portfolio Update Report & Advanced Swing Trade Entry Alerts - Newser
Braidwell LP Has $59.64 Million Holdings in Nuvalent, Inc. $NUVL - MarketBeat
Breakout Watch: Is Nuvalent Inc. stock forming a triangle patternJuly 2025 Trade Ideas & Precise Buy Zone Tips - خودرو بانک
Is now the right time to enter Nuvalent Inc.Quarterly Performance Summary & Technical Confirmation Trade Alerts - خودرو بانک
0.94%
0.17%
자본화:
|
볼륨(24시간):